HOME > COMMENTARY
COMMENTARY
-
COMMENTARY 2 articles
October 10, 2005
-
COMMENTARY 6 articles
September 19, 2005
-
Where Will the Japanese Pharmaceutical Industry Drift? - From "The Sky Is the Limit" to the Abyss -
August 29, 2005
-
COMMENTARY 5 articles
August 8, 2005
-
2 Rosai Hospitals Start Prescriptions by the Generic Name
July 25, 2005
-
COMMENTARY 6 articles
July 25, 2005
-
Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (3)
July 4, 2005
-
Former Reviewers' Interviews Make OPIR Report Exciting
June 27, 2005
-
Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (2)
June 27, 2005
-
Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (1)
June 20, 2005
-
Special Contribution
May 16, 2005
-
Japan's Most Admired Pharma Companies P. Reed Maurer President, NPP
April 18, 2005
-
PRTM Shows Results of Investigational Drug Survey
March 14, 2005
-
<Special Comtribution>
March 7, 2005
-
<Special Comtribution>
March 7, 2005
-
JPMA Update (12)
November 22, 2004
-
JPMA Pudate(11)
November 15, 2004
-
JPMA Update (10)
November 8, 2004
-
JPMA Update (9)
November 1, 2004
-
JPMA Update (8)
October 25, 2004
ページ
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
